Kansas Bioscience Authority considers investment
Keith Harrington, director of commercialization for the Kansas Bioscience Authority, talks about the KBA's most recent investment under consideration.
Advertisement
Keith Harrington, director of commercialization for the Kansas Bioscience Authority, talks about the KBA's most recent investment under consideration.
Comments
Use the comment form below to begin a discussion about this content.
Commenting has been disabled for this item.